Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, has appointed Dr. Michael Motz as chief commercial officer, Pharmaceuticals. Motz will join the company on June 1, 2021.   Motz is an entrepreneur and executive with over 25 years of industry experience and has held positions of increasing responsibility in both biotech and pharmaceutical compa...